Category

EU Related Items and Policy

Category

On 12 May, Advocate General (“A-G”) Hogan issued an Opinion in a case before the Court of Justice of the European Union (“CJEU”) concerning the application of the EU Blocking Statute (Regulation (EC) No 2271/96). While the Opinion is not binding on the CJEU, it signals that the EU and Member State courts are likely to take a strict approach in their interpretation of the Blocking Regulation, and highlights the complexities that face European businesses…

As part of its updated 2020 Industrial Strategy, the EU Commission noted that the pandemic has highlighted the trading bloc’s technological and industrial strategy dependencies, which need to be analysed and addressed as part of Europe’s economic recovery. The Commission presented the findings of a review of products imported into the EU on which the EU is highly dependent in notably sensitive sectors, along with the results of six in-depth reviews providing insights on the origin…

The Italian Government has blocked the export of 250,700 doses of COVID-19 vaccine to Australia. This decision represents the first application of the newly enacted EU transparency and authorization mechanism for exports of COVID-19 vaccines provided for by Implementing Regulation (EU) 2021/111 of January 29, 2021. This mechanism establishes that, until March 31, 2021, exports of COVID-19 vaccines are subject to the prior authorization by the Member State where products are manufactured with the purpose…

On 7 October 2020, the European Commission adopted the revised Annex I (the “Dual-Use List”) to Regulation 428/2009 (the “Dual-Use Regulation”) (see here). The new Dual-Use List came into force on 15 December 2020. The Dual-Use List is refreshed on an annual basis to take into account updates to international non-proliferation regimes and export control arrangements. The latest updates reflect changes from reviews carried out by the Wassenaar Arrangement in particular, and also from reviews…